Mother-to-child transmission

Vazquez, E.

Positively Aware the Monthly Journal of the Test Positive Aware Network 9(1): 15

1997


ISSN/ISBN: 1523-2883
PMID: 11364989
Document Number: 266634
The AIDS Clinical Trial Group 316 is enrolling pregnant HIV-positive women in a study to test the effectiveness of preventing mother-to-child infections. A single dose of nevirapine (Viramune) or a placebo will be given during labor, and all newborns will also be given AZT. Mothers will continue their antiretroviral therapy. Other current studies are looking at alternate combinations to prevent this kind of transmission. Contact information is given for enrolling in these trials and for support in continuing an HIV-positive pregnancy.

Document emailed within 1 workday
Secure & encrypted payments